FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048492401> ?p ?o ?g. }

• W3048492401 endingPage "102" @default.
• W3048492401 startingPage "93" @default.
• W3048492401 abstract "The concept of drug repurposing is extensively used currently to identify already approved/under investigation/discarded potential drugs for various other diseases, owing to the fact that many drugs could have multiple protein targets and many diseases share overlapping molecular pathways. The geographical spread of COVID-19 infections originating from Wuhan, China, has provided an opportunity to study the natural history of the recently emerged virus. The source of the SARS-CoV-2 is yet not known, even though the initial cases have been connected with the Huanan South China Seafood Market. In this study, the bioactivity of FDA-approved influenza drugs (Baloxavir, Oseltamivir, Peramivir and Zanamivir) were evaluated as inhibitors for COVID-19 using computational modeling approaches. The nominated drugs were docked on SARS-CoV-2 main protease (PDB ID: 6LU7) and also with SARS HCoV (PDB ID: 6NUR) for comparison, to evaluate the binding affinity of these drugs. ADMET and DFT analyses were also further carried out to analyze the potential of these influenza drugs as an effective inhibitor against COVID-19. The DFT calculations were performed to estimate the thermal parameters, dipole moment of the investigated drugs; additionally, chemical reactivity descriptors were investigated. The results of molecular docking with respect to binding energies in Kcal/mol suggested that binding affinity of influenza drugs with SARS-CoV-2 was in the order Zanamivir > Baloxavir > Oseltamivir > Peramivir. The findings of this study can facilitate rational drug design targeting the SARS-Cov-2 main protease." @default.
• W3048492401 created "2020-08-18" @default.
• W3048492401 creator A5014495294 @default.
• W3048492401 creator A5062862201 @default.
• W3048492401 creator A5090737758 @default.
• W3048492401 creator A5091208840 @default.
• W3048492401 date "2020-08-10" @default.
• W3048492401 modified "2023-10-03" @default.
• W3048492401 title "Computational Insights into the Drug Repurposing and Synergism of FDA-approved Influenza Drugs Binding with SARS-CoV-2 Protease against COVID-19" @default.
• W3048492401 doi "https://doi.org/10.12691/ajmr-8-3-3" @default.
• W3048492401 hasPublicationYear "2020" @default.
• W3048492401 type Work @default.
• W3048492401 sameAs 3048492401 @default.
• W3048492401 citedByCount "1" @default.
• W3048492401 countsByYear W30484924012023 @default.
• W3048492401 crossrefType "journal-article" @default.
• W3048492401 hasAuthorship W3048492401A5014495294 @default.
• W3048492401 hasAuthorship W3048492401A5062862201 @default.
• W3048492401 hasAuthorship W3048492401A5090737758 @default.
• W3048492401 hasAuthorship W3048492401A5091208840 @default.
• W3048492401 hasConcept C103637391 @default.
• W3048492401 hasConcept C142724271 @default.
• W3048492401 hasConcept C159047783 @default.
• W3048492401 hasConcept C181199279 @default.
• W3048492401 hasConcept C185592680 @default.
• W3048492401 hasConcept C18903297 @default.
• W3048492401 hasConcept C2776714187 @default.
• W3048492401 hasConcept C2779134260 @default.
• W3048492401 hasConcept C2780035454 @default.
• W3048492401 hasConcept C2780374985 @default.
• W3048492401 hasConcept C2781442963 @default.
• W3048492401 hasConcept C3007834351 @default.
• W3048492401 hasConcept C3008058167 @default.
• W3048492401 hasConcept C41685203 @default.
• W3048492401 hasConcept C42972112 @default.
• W3048492401 hasConcept C519536355 @default.
• W3048492401 hasConcept C524204448 @default.
• W3048492401 hasConcept C55493867 @default.
• W3048492401 hasConcept C64903051 @default.
• W3048492401 hasConcept C65556437 @default.
• W3048492401 hasConcept C70721500 @default.
• W3048492401 hasConcept C71240020 @default.
• W3048492401 hasConcept C71924100 @default.
• W3048492401 hasConcept C86803240 @default.
• W3048492401 hasConcept C98274493 @default.
• W3048492401 hasConceptScore W3048492401C103637391 @default.
• W3048492401 hasConceptScore W3048492401C142724271 @default.
• W3048492401 hasConceptScore W3048492401C159047783 @default.
• W3048492401 hasConceptScore W3048492401C181199279 @default.
• W3048492401 hasConceptScore W3048492401C185592680 @default.
• W3048492401 hasConceptScore W3048492401C18903297 @default.
• W3048492401 hasConceptScore W3048492401C2776714187 @default.
• W3048492401 hasConceptScore W3048492401C2779134260 @default.
• W3048492401 hasConceptScore W3048492401C2780035454 @default.
• W3048492401 hasConceptScore W3048492401C2780374985 @default.
• W3048492401 hasConceptScore W3048492401C2781442963 @default.
• W3048492401 hasConceptScore W3048492401C3007834351 @default.
• W3048492401 hasConceptScore W3048492401C3008058167 @default.
• W3048492401 hasConceptScore W3048492401C41685203 @default.
• W3048492401 hasConceptScore W3048492401C42972112 @default.
• W3048492401 hasConceptScore W3048492401C519536355 @default.
• W3048492401 hasConceptScore W3048492401C524204448 @default.
• W3048492401 hasConceptScore W3048492401C55493867 @default.
• W3048492401 hasConceptScore W3048492401C64903051 @default.
• W3048492401 hasConceptScore W3048492401C65556437 @default.
• W3048492401 hasConceptScore W3048492401C70721500 @default.
• W3048492401 hasConceptScore W3048492401C71240020 @default.
• W3048492401 hasConceptScore W3048492401C71924100 @default.
• W3048492401 hasConceptScore W3048492401C86803240 @default.
• W3048492401 hasConceptScore W3048492401C98274493 @default.
• W3048492401 hasIssue "3" @default.
• W3048492401 hasLocation W30484924011 @default.
• W3048492401 hasOpenAccess W3048492401 @default.
• W3048492401 hasPrimaryLocation W30484924011 @default.
• W3048492401 hasRelatedWork W3017404400 @default.
• W3048492401 hasRelatedWork W3023665270 @default.
• W3048492401 hasRelatedWork W3025443708 @default.
• W3048492401 hasRelatedWork W3034966578 @default.
• W3048492401 hasRelatedWork W3036643491 @default.
• W3048492401 hasRelatedWork W3044098226 @default.
• W3048492401 hasRelatedWork W3046738894 @default.
• W3048492401 hasRelatedWork W3047011861 @default.
• W3048492401 hasRelatedWork W3049073827 @default.
• W3048492401 hasRelatedWork W3090125556 @default.
• W3048492401 hasRelatedWork W3091183539 @default.
• W3048492401 hasRelatedWork W3093948127 @default.
• W3048492401 hasRelatedWork W3110202162 @default.
• W3048492401 hasRelatedWork W3124890765 @default.
• W3048492401 hasRelatedWork W3128695877 @default.
• W3048492401 hasRelatedWork W3128915734 @default.
• W3048492401 hasRelatedWork W3172771665 @default.
• W3048492401 hasRelatedWork W3197249797 @default.
• W3048492401 hasRelatedWork W3201340179 @default.
• W3048492401 hasRelatedWork W3090515615 @default.
• W3048492401 hasVolume "8" @default.
• W3048492401 isParatext "false" @default.
• W3048492401 isRetracted "false" @default.
• W3048492401 magId "3048492401" @default.

• next